期刊文献+

糖基化终末产物抑制骨髓间充质干细胞功能的机制

Mechanism of advanced glycation end products inhibiting function of bone mesenchymal stem cells
原文传递
导出
摘要 目的探讨糖基化终末产物(AGEs)对间充质干细胞(MSCs)增殖和迁移能力的影响及其机制。方法体外培养SD大鼠MSCs,流式细胞术鉴定阳性指标(CD29和CD90)和阴性指标(CD34和CD45)。噻唑蓝(Myr)比色法检测不同剂量(0、25、50、100、200mg/L)AGEs-牛血清白蛋白(BSA)在刺激不同时间(6、12、24h)后MSCs增殖变化。采用Wound—healing划痕实验检测不同剂量(0、25、50、100、200mg/L)AGEs—BSA刺激骨髓间充质干细胞24h后的迁移能力。荧光染色拍照测定AGEs—BSA(200mg/L)刺激12、24h后细胞内活性氧(ROS)累积情况。结果200mg/LAGEs—BSA刺激6、12、24hMSCs增殖能力显著下降,分别为81.22%、80.53%、51.50%,AGEs—BSA抑制细胞增殖呈时间和剂量依赖性。200mg/LAGEs—BSA刺激24h迁移能力下降[(0.012±0.006)μm/min比(0.022±0.002)μm/min,P〈0.01]。同时,细胞内的ROS在AGEs—BSA刺激下大量累积。结论AGEs—BSA刺激下通过其受体导致细胞内ROS累积,从而抑制细胞增殖和迁移能力。 Objective To explore the mechanism of advanced glycation end products (AGEs) attenuating the proliferation and migration in mesenchymal stem cells (MSCs). Methods The MSCs were isolated from male Sprague Dawley rats, and identified by flow cytometry ( positive : CD29 and CD90 ; negative: CD34 and CIM5). MSCs were stimulated by AGEs -bovine serum albumin (BSA) with different doses (0, 25, 50, 100 and 200 mg/L) and time (6, 12 and 24 h). The proliferation of cells was examined by methyl thiazol tetrazolium (MTF) assay. Wound - healing assay was used to assess the migration potential of cells treated with AGEs - BSA. Intracellular formation of reactive oxygen species (ROS) was evaluaed using a fluorescent probe. Results The relative metabolic activity was significantly reduced by 81.22%, 80. 53% and 51.50% with AGEs - BSA (200 mg/L) at 6, 12, and 24 h, respectively. The proliferation potential of MSCs was impacted by AGEs - BSA in a dose - and time - dependent manner. AGEs - BSA (200 mg/L for 24 h) obviously inhibited migration of MSCs [ (0. 012 ±0. 006) μm/min vs. (0. 022 ±0. 002) μm/min,P 〈0.01 ]. At the same time, AGEs - BSA significantly induced the intracellular ROS accumulation. Conclusion AGEs - BSA induced ROS formation via receptor to inhibit proliferation and migration.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2016年第2期436-438,共3页 Chinese Journal of Experimental Surgery
关键词 糖基化终末产物 骨髓间充质干细胞 增殖 迁移 Advanced glycation end products Bone mesenchymal stem cells Proliferation Migration
  • 相关文献

参考文献8

  • 1Voo, Dunaeva M, Eggermann J, et al. Diabetes mellitus impairs CD133 ~ progenitor cell function after myocardial infarction [ J ]. J Intern Med, 2009,265 ( 2 ) : 238 -249.
  • 2Jimenez-Quevedo P,Silva GV,Sanz-Ruiz R, et al. Diabetic and nondi- abetic patients respond differently to transendocardial injection of bone marrow mononuclear cells:findings from prospective clinical trials in "no-option" patients[ J]. Rev Esp Cardiol,2008,61 (6) :635-639.
  • 3Thornalley PJ. Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE) -an introduction [ J]. Mol Nutr Food Res, 2007,51 ( 9 ) : 1107-1110.
  • 4Kilhovd BK, Berg TJ, Birkeland KI, et al. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease [ J ]. Diabetes Care, 1999,22 ( 9 ) : 1543- 1548.
  • 5Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products sparking the development of diabetic vascular injury[ J]. Cir- culation,2006,114(6 ) :597-605.
  • 6Wei H, Li Z, Hu S, et al. Apoptosis of mesenchymal stem cells induced by hydrogen peroxide concerns both endoplasmic reticulum stress and mitochondrial death pathway through regulation of caspases, p38 and JNK [ J ]. J Cell Biochem ,2010,111 (4) :967-978.
  • 7Song H,Cha MJ, Song BW,et al. Reactive oxygen species inhibit ad- hesion of mesenchymal stem ceils implanted into ischemic myocardium via interference of focal adhesion complex[J]. Stem Cells, 2010,28 (3) :555-563.
  • 8Yao D, Brownlee M. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands[ J]. Diabetes,2010,59( 1 ) :249-255.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部